Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in <i>BRCA2</i> -altered Prostate TumorsGoutam Chakraborty, Philip W. Kantoff, Michael J. Morris et al.|Clinical Cancer Research|2020Cited by 21